written by reader Dave Lashmet’s new teaser stock for Obesity

By ldevitt, August 27, 2020

Any thoughts on Lashmet’s new teaser, a small biotech, under the radar with a Phase 3 completion within days or weeks? Also has a fast track pediatric designation.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.